Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

Linear Digitized Transition to form the crux of Liposomes Market

The global Liposomes Market is expected to stimulate at a good rate In Upcoming Years. Virtual consultations are amongst the ongoing trends. They mitigate the spreading of contagious ailments, thereby facilitating better efficiency. The gap regarding the demand-supply ratio could also be bridged this way. With this practice being followed, the developing economies would benefit better, as the cost to commute could be curtailed.

Liposomes are a novel system widely used in the field of drug delivery, gene delivery, medical imaging, and model cell membrane biology. Stealth liposome technology, DepoFoam technology, and non-PEGylated liposomal technology are gaining significant adoption in the development of liposome-based products. Growing research & development activities for the delivery of anti-fungal, anti-cancer, anti-inflammatory drugs, and therapeutic genes are boosting the demand for liposome formulations. Liposomes have the ability to overcome the limitations of conventional therapy and provide benefits in various therapeutic applications, ranging from cancer to pain management. Encapsulation of drugs in liposomes improves the therapeutic indices of various agents.

Get Going With Sample Of Liposomes Market Report! https://www.persistencemarketresearch.co/samples/16546

According to PMR, the global liposomes market was valued at US$ 6.5 Bn in 2019, and is expected to expand at a CAGR of around 7% during the forecast period (20202030).

Company Profiles:

  • Pfizer Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • Johnson & Johnson
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharma Industries Ltd
  • Baxter AG
  • Sanofi SA
  • Bristol Myers Squibb
  • Mylan NV
  • GlaxoSmithKline Plc.
  • Creative Biolabs
  • Precision NanoSystems Inc.
  • SkyePharma Inc.
  • Luye Pharma Group
  • Encapsula NanoSciences LLC
  • Nanovex Biotechnologies SL
  • Gilead Sciences, Inc.
  • Avanti Polar Lipids, Inc.
  • Fujifilm Holdings Corporation

Get A Customized Scope To Match Your Need Ask An Expert –  sales@persistencemarketresearch.com

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/16546

Key Takeaways from Liposomes Market Study

“Rising demand for liposomal formulations and vaccines, and increasing research activities in the field of biomolecules and gene delivery, are expected to favor the growth of the liposomes market,” says a PMR analyst.

Product Portfolio Expansion and Regulatory Approval – Key Strategies of Leading Liposome Manufacturers

Manufacturers in the liposomes market are focusing on product portfolio expansion and new product launches. For instance, in September 2017, Novartis received EU approval for the Rydapt® (midostaurin) drug for FLT3-mutated acute myeloid leukaemia (AML) and three types of advanced systemic mastocytosis. Manufacturers are focusing on acquiring regulatory approval in different countries for the expansion of product sales. For instance, in October 2017, GlaxoSmithKline Plc. declared that the US Food and Drug Administration approved Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles in adults aged 50 years and above.

Keeping A Tab On Key Players In The Liposomes Market? Go To “Purchase Now” To Decipher The Competitive Analysis In Our Liposomes Market Report! https://www.persistencemarketresearch.com/checkout/16546

More Valuable Insights on Liposomes Market

Persistence Market Research offers a unique perspective and actionable insights on the liposomes market in its latest study, presenting historical demand assessment of 20152019 and projections for 20202030, on the basis of product (simple liposomes, formulated liposomes {doxorubicin liposomes, amphotericin B liposomes, paclitaxel liposomes, cytarabine liposomes, irinotecan liposomes, cisplatin liposomes, and others}, and vaccines), application (drug delivery {cancer, fungal infection, viral & parasite infection, and others}, gene delivery/transfection, contrast agents for medical imaging, and model cell membranes), distribution channel (retail sales {academic & research laboratories, biopharmaceutical companies, clinical research organizations, and others} and distributional sales {hospital pharmacies, retail pharmacies, mail order pharmacies, and drug stores}), across seven major regions.

Related Reports:

Glycobiology Market

Treatment Syndromes Dementia Movement Disorders Market

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353

Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Call 1-888-863-3700

Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts